Executive record

Daniel Teper

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:daniel-teperVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims1 sources

Key Claims

Biography

Became President of the Company effective October 11, 2024. Also serves as CEO of NAYA Therapeutics Inc. since August 1, 2023.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2025 to end not publishedExecutive title: President · Organization not publishedIVF 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. IVF 10-K executive officers

    sec filing · Source published: Apr 30, 2025 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at INVO Fertility, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President · Claim reviewed: May 16, 2026
    • Other Company Role: Daniel Teper is also linked to NAYA Therapeutics Inc. (NTI) as Chief Executive Officer. · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026